These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8884975)

  • 41. Retinopathy after irradiation for Graves' ophthalmopathy.
    Nikoskelainen E; Joensuu M
    Lancet; 1989 Sep; 2(8664):690-1. PubMed ID: 2570949
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effects of external orbital radiotherapy on the oculomotor muscle in Graves disease].
    Maalouf T; Angioi-Duprez K; Beckendorff V; Malet T; George JL
    J Fr Ophtalmol; 1996; 19(12):748-54. PubMed ID: 9033899
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Graves' ophthalmopathy in patients treated with radioiodine 131-I.
    Bałdys-Waligórska A; Gołkowski F; Kusnierz-Cabala B; Buziak-Bereza M; Hubalewska-Dydejczyk A
    Endokrynol Pol; 2011; 62(3):214-9. PubMed ID: 21717402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters.
    Gerding MN; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2000 May; 52(5):641-6. PubMed ID: 10792345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Supervoltage orbital radiotherapy in 36 cases of Graves' disease.
    Lloyd WC; Leone CR
    Am J Ophthalmol; 1992 Apr; 113(4):374-80. PubMed ID: 1558110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The aftermath of orbital radiotherapy for graves' ophthalmopathy.
    Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Buettner H; Robertson DM; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
    Ophthalmology; 2002 Nov; 109(11):2100-7. PubMed ID: 12414422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Letter: Orbital radiation in Graves' disease.
    Rubenzik R
    Am J Ophthalmol; 1975 May; 79(5):888-9. PubMed ID: 1173740
    [No Abstract]   [Full Text] [Related]  

  • 48. Long-term safety of orbital radiotherapy for Graves' ophthalmopathy.
    Marcocci C; Bartalena L; Rocchi R; Marinò M; Menconi F; Morabito E; Mazzi B; Mazzeo S; Sartini MS; Nardi M; Cartei F; Cionini L; Pinchera A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3561-6. PubMed ID: 12915636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Graves' ophthalmopathy--a prospective clinical study].
    Bogdănici C; Marcu C
    Oftalmologia; 1999; 48(3):19-22, 25. PubMed ID: 10641113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The combined therapy of Basedow's ophthalmopathy with retrobulbar radiotherapy and i.v. immunoglobulins. The preliminary results].
    Antonelli A; Saracino A; Alberti B; Melosi A; Cartei F; Lepri A; Laddaga M; Baschieri L
    Clin Ter; 1992 Jan; 140(1):25-31. PubMed ID: 1526094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Graves' ophthalmopathy by steroid therapy, orbital radiation therapy, plasmapheresis and thyroxine replacement.
    Yamamoto K; Saito K; Takai T; Yoshida S
    Endocrinol Jpn; 1982 Aug; 29(4):495-501. PubMed ID: 6897533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study.
    Marcocci C; Bartalena L; Panicucci M; Marconcini C; Cartei F; Cavallacci G; Laddaga M; Campobasso G; Baschieri L; Pinchera A
    Clin Endocrinol (Oxf); 1987 Jul; 27(1):33-42. PubMed ID: 3308192
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy.
    Wiersinga WM; Smit T; Schuster-Uittenhoeve AL; van der Gaag R; Koornneef L
    Ophthalmologica; 1988; 197(2):75-84. PubMed ID: 3186212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Smoking and risk of Graves' disease.
    Prummel MF; Wiersinga WM
    JAMA; 1993 Jan; 269(4):479-82. PubMed ID: 8419666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy.
    Prummel MF; Mourits MP; Blank L; Berghout A; Koornneef L; Wiersinga WM
    Lancet; 1993 Oct; 342(8877):949-54. PubMed ID: 8105213
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Orbital radiotherapy for Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Pinchera A
    J Clin Endocrinol Metab; 2004 Jan; 89(1):13-4. PubMed ID: 14715819
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.
    Mourits MP; Prummel MF; Wiersinga WM; Koornneef L
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):9-14. PubMed ID: 9302365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thyroid diseases after treatment of Hodgkin's disease.
    Hancock SL; Cox RS; McDougall IR
    N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined irradiation and low-dose cyclophosphamide in the treatment of Graves' ophthalmopathy.
    Teoh R; Woo J
    Postgrad Med J; 1987 Sep; 63(743):777-9. PubMed ID: 3444803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.